American Research & Management Co. Amgen Inc Transaction History

American Research & Management Co.

$362 Million
Q3 2022

A detailed history of American Research & Management Co. transactions in Amgen Inc stock. As of the latest transaction made, American Research & Management Co. holds 3,539 shares of AMGN stock, worth $1.09 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

3,539

Previous 3,579 1.12%

Holding current value

$1.09 Million

Previous $871,000 8.38%

% of portfolio

0.22%

Previous 0.22%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 07, 2022	SELL	$224.46 - $253.15 $8,978 - $10,126	-40 Reduced 1.12%	3,539 $798,000
Q2 2022 Jul 22, 2022	SELL	$230.71 - $256.74 $131,966 - $146,855	-572 Reduced 13.78%	3,579 $871,000
Q4 2021 Jan 28, 2022	SELL	$198.88 - $227.6 $14,916 - $17,070	-75 Reduced 1.77%	4,151 $934,000
Q3 2021 Oct 28, 2021	SELL	$212.27 - $248.7 $15,920 - $18,652	-75 Reduced 1.74%	4,226 $899,000
Q2 2021 Jul 16, 2021	SELL	$233.58 - $259.14 $85,023 - $94,326	-364 Reduced 7.8%	4,301 $1.05 Million

Q1 2021 Apr 06, 2021	SELL	$221.91 - $258.6 $27,738 - $32,325	-125 Reduced 2.61%	4,665 $1.16 Million
Q4 2020 Jan 28, 2021	BUY	$216.38 - $257.67 $27,047 - $32,208	125 Added 2.68%	4,790 $1.1 Million
Q3 2020 Oct 29, 2020	BUY	$234.65 - $260.95 $12,905 - $14,352	55 Added 1.19%	4,665 $1.19 Million
Q2 2020 Jul 28, 2020	BUY	$197.81 - $242.74 $3,164 - $3,883	16 Added 0.35%	4,610 $1.09 Million
Q3 2019 Oct 31, 2019	SELL	$174.11 - $208.62 $29,598 - $35,465	-170 Reduced 3.57%	4,594 $889,000
Q2 2019 Jul 18, 2019	SELL	$166.7 - $195.41 $166,700 - $195,410	-1,000 Reduced 17.35%	4,764 $878,000
Q1 2019 Apr 16, 2019	BUY	$180.87 - $203.88 $180,870 - $203,880	1,000 Added 20.99%	5,764 $1.1 Million
Q4 2018 Feb 12, 2019	BUY	$178.4 - $208.25 $15,520 - $18,117	87 Added 1.86%	4,764 $927,000
Q2 2018 Jul 25, 2018	SELL	$166.05 - $186.51 $33,210 - $37,302	-200 Reduced 4.1%	4,677 $863,000
Q1 2018 Apr 19, 2018	SELL	$169.43 - $198.0 $12,707 - $14,850	-75 Reduced 1.51%	4,877 $831,000
Q4 2017 Feb 08, 2018	BUY	$168.79 - $188.59 $16,879 - $18,859	100 Added 2.06%	4,952 $861,000
Q3 2017 Oct 17, 2017	BUY	$167.29 - $191.0 $811,691 - $926,732	4,852	4,852 $905,000

Others Institutions Holding AMGN

# of Institutions

2,933

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $165B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Research & Management Co., based on Form 13F filings with the SEC.

News

Stay updated on American Research & Management Co. with notifications on news.

Account

American Research & Management Co. Amgen Inc Transaction History